Back to User profile » Dr Jan Sperl
Papers published by Dr Jan Sperl:
Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy
Hézode C, Kwo P, Sperl J, Hwang P, Long J, Talwani R, Robertson MN, Haber BA
International Journal of Women's Health 2019, 11:617-628
Published Date: 20 November 2019
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
Ng X, Nwankwo C, Arduino JM, Corman S, Lasch KE, Lustrino JM, Patel S, Platt HL, Qiu J, Sperl J
Patient Preference and Adherence 2018, 12:2631-2638
Published Date: 11 December 2018
Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis
Sperl J, Frankova S, Kreidlova M, Merta D, Tothova M, Spicak J
Therapeutics and Clinical Risk Management 2017, 13:733-738
Published Date: 22 June 2017
USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study
Frankova S, Jirsa M, Merta D, Neroldova M, Urbanek P, Senkerikova R, Spicak J, Sperl J
Therapeutics and Clinical Risk Management 2015, 11:1853-1861
Published Date: 17 December 2015